Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes
β Scribed by Aristoteles Giagounidis; Pierre Fenaux; Ghulam J. Mufti; Petra Muus; Uwe Platzbecker; Guillermo Sanz; Larry Cripe; Marie Von Lilienfeld-Toal; Richard A. Wells
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 167 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The myelodysplastic syndromes (MDS) are a group of malignancies with poor prognosis and obscure etiology. To better understand the distribution of MDS in the population and help generate etiologic hypotheses, we assessed potential clustering in the incidence of MDS in the state of Connecticut using
The FAB group has defined myelodysplasia in adults but direct application of this categorization to children has been controversial. Consequently, to outline the natural history of the disease better we have retrospectively analysed case reports and series published in English between 1982 and 1996.